AstraZeneca Becomes Regulus Therapeutics’ Third Big Pharma Collaborator
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 8 (Table of Contents)
Published: 31 Aug-2012
DOI: 10.3833/pdr.v2012.i8.1796 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
AstraZeneca and Regulus Therapeutics have partnered for the discovery, development and commercialisation of microRNA (miRNA) therapeutics for three exclusive targets that are in preclinical development...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS